Abstracts

DAILY ORAL PREP IS EFFECTIVE AMONG WOMEN WITH ABNORMAL VAGINAL MICROBIOTA

Daily oral tenofovir-based PrEP demonstrated high efficacy in clinical trials for HIV prevention among women with high adherence. Recent data suggest that vaginal tenofovir gel may not effectively prevent HIV among women with bacterial vaginosis or other indicators of vaginal dysbiosis (e.g., non-Lactobacillus or Gardnerella¬ predominance). Those data raised concern whether daily oral tenofovir could…

INITIATION OF ART BASED ON INTEGRASE INHIBITORS INCREASES THE RISK OF IRIS

Immunocompromised HIV-infected patients frequently initiate ART based on integrase inhibitors (INSTI). Together with a low CD4 T cell count and a high likelihood of opportunistic infection, the sharp control of viral replication associated with INSTI-based ART might synergize the risk of immune reconstitution inflammatory syndrome (IRIS). Our aim was to determine the incidence of IRIS…

INFLAMMASOMES PLAY A MAJOR ROLE IN TB IRIS PATHOGENESIS

Tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) affects 20% of patients with TB and HIV after antiretroviral therapy (ART) initiation. It is associated with significant morbidity and its pathogenesis is still not fully elucidated. We identified differentially expressed RNA transcripts between TB/HIV co-infected patients with and without IRIS. Subjects in this cohort study (NCT01611402) were…

THE DIABETES-TUBERCULOSIS COMORBIDITY AMONG PERSONS WITH HIV

Both HIV and Diabetes mellitus (DM) increase the risk of developing Tuberculosis (TB). While many studies addressed the relationship between HIV infection the risk of DM, the relationship between HIV infection and the co-morbidity tuberculosis-diabetes is still poorly explored. We performed a retrospective study on 2395 adult patients consecutively diagnosed with TB in 7 European…

RISK PROFILES IN MONOINFECTED TB PATIENTS AND THOSE COINFECTED WITH HCV AND/OR HIV

Acquisition risk factors for Hepatitis C Virus (HCV), HIV and tuberculosis (TB) are often shared or may differ between populations. Groups with different infection combinations may represent subpopulations with unique demographic and risk characteristics. Understanding the shared and differing risk factors between populations is key to developing targeted prevention strategies. We used diagnostic testing, co-infection…

PROBLEM DRUG USE PREDICTS HIGHER HIV PREVALENCE IN UK TUBERCULOSIS CASES, 2010–2014

HIV co-infection in tuberculosis (TB) patients is associated with poorer outcomes; including higher rates of recurrence, adverse events, treatment interruption or non-completion, and death. Black African ethnicity and being born in sub-Saharan Africa are known predictors of HIV co-infection. We identified adults aged ≥15 years diagnosed with TB from 2010-2014 in England, Wales and Northern…

GENETIC VARIATION IN EIF2AK3 IS ASSOCIATED WITH NEUROCOGNITIVE IMPAIRMENT IN HIV

Despite its continued high prevalence, genetic vulnerability to HIV-associated neurocognitive impairment (NCI) remains less well understood than in the general population. Risk factors for NCI (e.g., HIV replication, persistent inflammation) can induce the ubiquitous unfolded protein response (UPR), which activates initiator proteins that can phosphorylate eukaryotic translation initiation factor 2α (eIF2α) and subsequently, slow global…